BofA Securities analyst Alec W. Stranahan raised the price target on Agios Pharma (NASDAQ: AGIO) to $44.00 (from $35.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE